Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ramos

Showing results (211-220 of 223) with videos related to

Pageof 23
Sort By:
Georgian Medical News|November 25, 2022
SAFETY AND EFFICACY OF THYMIC PEPTIDES IN THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS IN HONDURASH Ramos-Zaldívar, K Reyes-Perdomo, N Espinoza-Moreno, et al.
Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.
Nature|July 24, 2012
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutationsTrevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, et al.
Nature|May 25, 2012
Melanoma genome sequencing reveals frequent PREX2 mutationsMichael F Berger, Eran Hodis, Timothy P Heffernan, et al.
Nature Genetics|July 6, 2010
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Barry S Taylor, Shantanu Banerji, et al.
Nature Genetics|May 22, 2012
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerChristopher E Barbieri, Sylvan C Baca, Michael S Lawrence, et al.
Nature Genetics|October 6, 2009
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasAdam J Bass, Hideo Watanabe, Craig H Mermel, et al.
Nature|March 25, 2011
Initial genome sequencing and analysis of multiple myelomaMichael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Nature|June 23, 2012
Sequence analysis of mutations and translocations across breast cancer subtypesShantanu Banerji, Kristian Cibulskis, Claudia Rangel-Escareno, et al.
Cancer Discovery|February 14, 2012
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancerPeter S Hammerman, Martin L Sos, Alex H Ramos, et al.
Pageof 23

Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
Georgian Medical News|November 25, 2022
SAFETY AND EFFICACY OF THYMIC PEPTIDES IN THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS IN HONDURASH Ramos-Zaldívar, K Reyes-Perdomo, N Espinoza-Moreno, et al.
Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.
Nature|July 24, 2012
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutationsTrevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, et al.
Nature|May 25, 2012
Melanoma genome sequencing reveals frequent PREX2 mutationsMichael F Berger, Eran Hodis, Timothy P Heffernan, et al.
Nature Genetics|July 6, 2010
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Barry S Taylor, Shantanu Banerji, et al.
Nature Genetics|May 22, 2012
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerChristopher E Barbieri, Sylvan C Baca, Michael S Lawrence, et al.
Nature Genetics|October 6, 2009
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasAdam J Bass, Hideo Watanabe, Craig H Mermel, et al.
Nature|March 25, 2011
Initial genome sequencing and analysis of multiple myelomaMichael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Nature|June 23, 2012
Sequence analysis of mutations and translocations across breast cancer subtypesShantanu Banerji, Kristian Cibulskis, Claudia Rangel-Escareno, et al.
Cancer Discovery|February 14, 2012
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancerPeter S Hammerman, Martin L Sos, Alex H Ramos, et al.
Pageof 23